Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA — Los Angeles, California

Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma.

Sponsors: University of California, San Diego.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

• University of California Los Angeles School of Medicine
• Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
• VA Greater Los Angeles Health System
• Usc/Norris Comprehensive Cancer Center Hospital
• University of Southern California - PT Associates
• University of Southern California Keck School of Medicine/University of Southern California LAC & USC Medical Center
• UCLA Orthodpedic Hospital
• University of Southern California /ID# 164095
• Keck hospital of the University of Southern California
• Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center
• University of California Los Angeles - Division of Dermatology
• University California Los Angeles Medical Center (UCLA)

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA?

Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA conducted?

Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has 1 clinical trials on record. Their work covers Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma.

Is Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA accredited by Crixeo Clinical Trials?

Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.